Results reported herein demonstrate that STS was present in 68% of the ovarian tumors, a frequency similar to that previously described in clear cells ovarian carcinoma [18], with the enzyme being localized in the cytoplasm of epithelial tumor cell, as previously shown by immunohistochemistry in epithelial ovarian cancer [18, 20]. Here, STS is linked to ovarian carcinoma.